1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Waldenstrom's Disease: new trials by email Literature Review of Waldenstrom's Disease trials Research Report on Waldenstrom's Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daratumumab Plus Ibrutinib in Patients With WaldenstrÓ§m's Macroglobulinemia Ibrutinib, Daratumumab - Waldenstrom Macroglobulinemia, Waldenstrom's Disease | Phase 2 | Terminated | Weill Medical College of Cornell University | 1 | 2020-07-30 | 2023-10-23 |
Hypergammaglobulinemia (1) · Recurrence (1) · Waldenstrom Macroglobulinemia (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1)
daratumumab (1) · ibrutinib (1)
Weill Medical College of Cornell University (1)
United States (1)